Quantcast Venaxis' APPY1 Test Passes Futility Analysis In Pivotal Clinical Study - Congoo
Venaxis' APPY1 Test Passes Futility Analysis in Pivotal Clinical Study
Have an interest in this Story?
Sign Up for Real-Time email updates
KRHD TV  | July 15, 2013

SOURCE Venaxis, Inc. Company Provides Clinical and Corporate Update Company to Host Conference Call and Webcast Tuesday, July 16, 2013, 8:30 a.m. ET CASTLE ROCK, Colo. The futility analysis, which consisted of an independent review of the validity, integrity, and clinical and scientific relevan...
Read Full Article   
Leave a Comment: You must be logged in to leave a comment     Log in | Register

Featured Members
Sylvia M. Romagosa, MBA Sylvia M. Romagosa, MBA
Licensed Real Estate Broker
Real Estate Industry
Sergio Waldeck, MBA Sergio Waldeck, MBA
Director of Financial Planning and Analysis

  View more profiles

Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2015 Congoo.com. All Rights Reserved.